Loading...
NPI 1992809586 · Baltimore, MD · Community/Retail Pharmacy
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Northern Pharmacy And Medical Equipment, Inc is a community/retail pharmacy provider located in Baltimore, Maryland. This profile covers 13 Medicare and 101 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Northern Pharmacy And Medical Equipment, Inc |
| Address | 6701 Harford Rd |
| City | Baltimore |
| State | MD |
| ZIP | 21234 |
| Taxonomy | Community/Retail Pharmacy |
| NPI Enumerated | September 12, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $14.2M |
| Medicare | $168.6K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
13 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 91322 | This code represents a SARS–CoV–2 vaccine product administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 50 mcg/0.5 mL. | 470 | $140 | $67.4K |
| 90480 | The provider administers the first or only component of a SARS–CoV–2 (COVID–19) vaccine by intramuscular injection to reduce the patient's risk of contracting COVID–19. | 520 | $40 | $22.4K |
| 90694 | This code represents a vaccine product administered into the muscle to protect against four strains of influenza (flu). It is an inactivated, adjuvanted, preservative–free vaccine given as a 0.5 mL… | 280 | $80 | $21.2K |
| G0008 | Administration of influenza virus vaccine | 630 | $30 | $16.5K |
| 90662 | This code represents a flu vaccine product that is a split virus type, contains no preservatives, and has enhanced effectiveness due to a higher antigen content. It is administered as an injection… | 190 | $70 | $14K |
| 91320 | This code represents a SARS–CoV–2 vaccine product (tris–sucrose formulation) administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 30 mcg/0.3 mL. | 50 | $130 | $6.5K |
| 90677 | This code represents a vaccine product administered intramuscularly to protect against pneumococcal disease, a bacterial infection. This is a 20–valent vaccine, protecting against 20 strains of the… | 20 | $280 | $5.9K |
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | 430 | $10 | $5.2K |
| 0124A | N/A | 80 | $40 | $3.5K |
| 90686 | This code represents a vaccine product administered into the muscle to protect against four strains of influenza (flu). It is preservative free, uses split virus technology, and is given as a 0.5 mL… | 150 | $20 | $3.3K |
Showing 1–10 of 13
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 13 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
13 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| 91322 | 25 | 680 | 90 | $140 | $19.4K |
| 91320 | 359 | 660 | 60 | $130 | $15K |
| K1034 | 258 | 520 | 430 | $10 | $10.7K |
| 90677 | 778 | 1,390 | 20 | $280 | $8.6K |
| 90694 | 93 | 1,290 | 60 | $70 | $7.7K |
| 90480 | 38 | 1,080 | 100 | $40 | $6.4K |
| 90662 | 138 | 1,650 | 60 | $70 | $5.8K |
| G0008 | 22 | 2,790 | 60 | $30 | $3.4K |
| 0124A | 55 | 540 | 30 | $40 | $2K |
| 0134A | 152 | 520 | 30 | $40 | $1.8K |
Showing 1–10 of 13
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
101 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| A9276 | Sensor; invasive (e.g., subcutaneous), disposable, for use with non-durable medical equipment interstitial continuous glucose monitoring system, one unit = 1 day supply | 4,010 | $510 | $2.1M |
| T4527 | Adult sized disposable incontinence product, protective underwear/pull-on, large size, each | 9,570 | $130 | $1.2M |
| T4526 | Adult sized disposable incontinence product, protective underwear/pull-on, medium size, each | 8,930 | $130 | $1.1M |
| T4528 | Adult sized disposable incontinence product, protective underwear/pull-on, extra large size, each | 8,970 | $120 | $1.1M |
| A4927 | Gloves, non-sterile, per 100 | 36,650 | $30 | $953K |
| T4535 | Disposable liner/shield/guard/pad/undergarment, for incontinence, each | 15,070 | $50 | $768.5K |
| A4554 | Disposable underpads, all sizes | 16,040 | $40 | $641.7K |
| T4523 | Adult sized disposable incontinence product, brief/diaper, large, each | 4,200 | $120 | $516.8K |
| T4541 | Incontinence product, disposable underpad, large, each | 13,450 | $40 | $510.9K |
| B4035 | Enteral feeding supply kit; pump fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape | 15,550 | $30 | $451.1K |
Showing 1–10 of 101
How this provider's Medicaid billing volume and revenue compare to other Maryland providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Maryland median
101 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| A9276 | Sensor; invasive (e.g., subcutaneous), disposable, for use with non-durable medical equipment interstitial continuous glucose monitoring system, one unit = 1 day supply | 2 | 10 | 1,500 | $1,100 | $2.5M |
| B4161 | Enteral formula, for pediatrics, hydrolyzed/amino acids and peptide chain proteins, includes fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding… | 12 | 10 | 1,030 | $450 | $1.1M |
| B4035 | Enteral feeding supply kit; pump fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape | 4 | 30 | 1,500 | $150 | $899.7K |
| T4526 | Adult sized disposable incontinence product, protective underwear/pull-on, medium size, each | 8 | 40 | 2,410 | $140 | $800.1K |
| T4527 | Adult sized disposable incontinence product, protective underwear/pull-on, large size, each | 10 | 50 | 1,360 | $150 | $673.9K |
| T4535 | Disposable liner/shield/guard/pad/undergarment, for incontinence, each | 14 | 70 | 2,520 | $60 | $489.7K |
| T4528 | Adult sized disposable incontinence product, protective underwear/pull-on, extra large size, each | 4 | 40 | 1,280 | $140 | $472.5K |
| A9278 | Receiver (monitor); external, for use with non-durable medical equipment interstitial continuous glucose monitoring system | 2 | 10 | 440 | $1,080 | $471.6K |
| A9277 | Transmitter; external, for use with non-durable medical equipment interstitial continuous glucose monitoring system | 2 | 10 | 1,270 | $280 | $468.7K |
| B4160 | Enteral formula, for pediatrics, nutritionally complete calorically dense (equal to or greater than 0.7 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals,… | 7 | 20 | 1,040 | $160 | $444.8K |
Showing 1–10 of 101
Other providers in the same ZIP code as Northern Pharmacy And Medical Equipment, Inc, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.